Showing 1,510 results

Filters Content type: News, Editors' picks Topic: Pharmaceutical industry

News and information on drug companies, the cost of therapies, patent protections and generic medicines.

New & experimental HIV treatments

Gilead’s Quad Pill Raises Kidney Questions, FDA Says

Editor's pick
Bloomberg Business Week
9 May 2012
Access to healthcare

Dean Baker: Bernie Sanders Advocates a Free Market in AIDS Drugs

Editor's pick
Huffington Post
8 May 2012
New & experimental hepatitis C treatment

Bristol-Myers Missing Hep C Data Raises Red Flags, May Boost Gilead, Idenix

Editor's pick
The Street
8 May 2012
Neurological & cognitive problems

Pfizer Says Lyrica Fails in Diabetes Trial, Halts HIV Study

Editor's pick
Bloomberg
4 May 2012
Access to healthcare

Colombian Court: Abbott Labs' pricing abuse violated health rights

Editor's pick
Public Citizen
30 April 2012
PrEP

Truvada PrEP, Gilead, AHF's Bizarre Attack: Our Statement to the FDA

Editor's pick
AIDS Treatment News
30 April 2012
Pharmaceutical industry

Gilead Sciences 1Q profit down on Pharmasset costs

Editor's pick
CBS News
27 April 2012
New & experimental hepatitis C treatment

Grading Hep C Stocks Exiting EASL - The future of hepatitis C therapy belongs to interferon-free regimens

Editor's pick
The Street
23 April 2012
New & experimental hepatitis C treatment

J&J Open to Expanding Hepatitis C Collaboration With Vertex

Editor's pick
HCV New Drugs Research
20 April 2012
New & experimental hepatitis C treatment

Pancreatitis Forces Halt to HCV Drug Trial

Editor's pick
MedPage Today
20 April 2012
New & experimental hepatitis C treatment

Janssen Creates new Division to Launch TMC435 and Help Conquer Hepatitis C in EMEA

Editor's pick
Janssen press release
20 April 2012
New & experimental hepatitis C treatment

Gilead, Bristol-Myers Squibb Put Profits Ahead of Best Care for Hep C Patients

Editor's pick
The Street
20 April 2012
New & experimental hepatitis C treatment

More Hep C Drug Abstracts Leak Ahead of EASL Confab

Editor's pick
The Street
12 April 2012
Pharmaceutical industry

Abbott sues Boehringer's Roxane over Norvir HIV drug patents

Editor's pick
Chicago Daily Herald
11 April 2012
Pharmaceutical industry

Gilead And The Future of HIV Therapy

Editor's pick
The Street
10 April 2012
New & experimental hepatitis C treatment

Winners, Losers From EASL Hepatitis C Data Dump

Editor's pick
The Street
10 April 2012
New & experimental hepatitis C treatment

What You Don’t Know, You Can Sell: Merck’s Cavalier Attitude Towards the Welfare of HIV/HCV Coinfected Patients

Editor's pick
TAG
10 April 2012
Pharmaceutical industry

Making drugs into profit in Uganda

Editor's pick
BBC Health
10 April 2012
Pharmaceutical industry

Four busted in $150M HIV/AIDS-Medicaid drug scam

Editor's pick
New York Post
4 April 2012
New & experimental HIV treatments

GSK's new once-daily HIV drug matches Merck rival

Editor's pick
Reuters
2 April 2012
New & experimental HIV treatments

Shionogi-ViiV Healthcare Announces Initial Data from Pivotal Phase III Study

Editor's pick
ViiV Healthcare (press release)
2 April 2012
Pharmaceutical industry

Abbott Selects AbbVie as New Name for Future Research-Based Pharmaceutical Company

Editor's pick
Abbott press release
23 March 2012
Access to healthcare

Brazil HIV Drug Patent Ruling Allows Generics, Sends Pipeline Process Into Doubt

Editor's pick
Intellectual Property Watch
23 March 2012
New & experimental HIV treatments

Avexa closer to EMA approval for ATC

Editor's pick
Australian Life Scientist
23 March 2012